Skip to main content

Amgen XGEVA revenue

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

XGEVA revenue at Amgen came to $288.0M for the quarter to 30 Sep 2026, down 46.6% from a year earlier.

As Amgen reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$527.0MDec 2023$561.0MMar 2024$562.0MJun 2024$541.0MSep 2024$561.0MDec 2024$566.0MMar 2025$532.0MJun 2025$539.0MSep 2025$447.0MDec 2025$411.0MMar 2026$352.0MJun 2026$288.0MSep 2026
Amgen XGEVA revenue, every reported period
Period endingXGEVA revenueChange on a yearFiled
30 Sep 2026$288.0Mdown 46.6%4 Nov 2026
30 Jun 2026$352.0Mdown 33.8%5 Aug 2026
31 Mar 2026$411.0Mdown 27.4%1 May 2026
31 Dec 2025$447.0Mdown 20.3%13 Feb 2026
30 Sep 2025$539.0Mdown 0.4%5 Nov 2025
30 Jun 2025$532.0Mdown 5.3%6 Aug 2025
31 Mar 2025$566.0Mup 0.9%2 May 2025
31 Dec 2024$561.0Mup 6.5%14 Feb 2025
30 Sep 2024$541.0Mup 4.2%31 Oct 2024
30 Jun 2024$562.0Mup 6.0%7 Aug 2024
31 Mar 2024$561.0Mup 4.7%3 May 2024
31 Dec 2023$527.0Mup 8.9%14 Feb 2024
30 Sep 2023$519.0Mup 4.8%31 Oct 2023
30 Jun 2023$530.0Mdown 0.6%4 Aug 2023
31 Mar 2023$536.0Mup 6.8%28 Apr 2023
31 Dec 2022$484.0Mdown 11.2%9 Feb 2023
30 Sep 2022$495.0Mdown 4.3%4 Nov 2022
30 Jun 2022$533.0Mup 9.2%5 Aug 2022
31 Mar 2022$502.0Mup 7.3%28 Apr 2022
31 Dec 2021$545.0Mup 8.6%16 Feb 2022
30 Sep 2021$517.0Mup 7.5%3 Nov 2021
30 Jun 2021$488.0Mup 12.2%4 Aug 2021
31 Mar 2021$468.0Mdown 2.7%28 Apr 2021
31 Dec 2020$502.0Mup 2.7%9 Feb 2021
30 Sep 2020$481.0Mup 1.1%29 Oct 2020
30 Jun 2020$435.0Mdown 12.8%29 Jul 2020
31 Mar 2020$481.0Mup 2.1%1 May 2020
31 Dec 2019$489.0Mup 7.2%12 Feb 2020
30 Sep 2019$476.0Mup 9.9%30 Oct 2019
30 Jun 2019$499.0Mup 10.4%31 Jul 2019
31 Mar 2019$471.0Mup 5.8%1 May 2019
31 Dec 2018$456.0M—13 Feb 2019
30 Sep 2018$433.0Mup 11.9%31 Oct 2018
30 Jun 2018$452.0Mup 14.4%27 Jul 2018
31 Mar 2018$445.0M—25 Apr 2018
30 Sep 2017$387.0M—26 Oct 2017
30 Jun 2017$395.0M—26 Jul 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Amgen: Product sales · Repatha revenue · EVENITY revenue · Prolia revenue · ENBREL revenue · TEZSPIRE revenue · TEPEZZA revenue · BLINCYTO revenue · Otezla revenue · Nplate revenue · UPLIZNA revenue · KRYSTEXXA revenue · IMDELLTRA/IMDYLLTRA revenue · Vectibix revenue · KYPROLIS revenue · Aranesp revenue · United States revenue · ROW revenue · financial statements

Every KPI and segment of AMGN, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.